| Primary |
| Pain |
40.7% |
| Drug Use For Unknown Indication |
22.0% |
| Trigeminal Neuralgia |
11.9% |
| Back Pain |
3.4% |
| Cervicobrachial Syndrome |
3.4% |
| Fibromyalgia |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Abdominal Pain Upper |
1.7% |
| Bone Disorder |
1.7% |
| Bone Pain |
1.7% |
| Epilepsy |
1.7% |
| Essential Hypertension |
1.7% |
| Neuralgia |
1.7% |
| Postoperative Analgesia |
1.7% |
|
| Pneumonia |
14.3% |
| Blood Testosterone Decreased |
7.1% |
| Hepatitis |
7.1% |
| Suicide Attempt |
7.1% |
| Therapeutic Agent Toxicity |
7.1% |
| Vomiting |
7.1% |
| Erectile Dysfunction |
3.6% |
| Hypoaesthesia |
3.6% |
| Hypoglycaemia |
3.6% |
| Hypogonadism Male |
3.6% |
| Insulinoma |
3.6% |
| Intentional Drug Misuse |
3.6% |
| International Normalised Ratio Increased |
3.6% |
| Intracranial Pressure Increased |
3.6% |
| Nausea |
3.6% |
| Oedema Peripheral |
3.6% |
| Palpitations |
3.6% |
| Prothrombin Time Abnormal |
3.6% |
| Prothrombin Time Shortened |
3.6% |
| Rash Generalised |
3.6% |
|
| Secondary |
| Pain |
31.3% |
| Procedural Pain |
11.0% |
| Back Pain |
9.8% |
| Intentional Overdose |
7.4% |
| Neck Pain |
5.5% |
| Depression |
4.9% |
| Thrombosis Prophylaxis |
4.9% |
| Coronary Artery Disease |
3.7% |
| Drug Use For Unknown Indication |
2.5% |
| Hypertension |
2.5% |
| Polyneuropathy |
2.5% |
| Prophylaxis |
2.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
| Fibromyalgia |
1.8% |
| Arrhythmia |
1.2% |
| Arthralgia |
1.2% |
| Bone Pain |
1.2% |
| Epilepsy |
1.2% |
| Infection Prophylaxis |
1.2% |
| Product Used For Unknown Indication |
1.2% |
|
| Unresponsive To Stimuli |
11.9% |
| Vomiting |
9.5% |
| Pneumonia |
7.1% |
| Sinus Bradycardia |
7.1% |
| Therapeutic Agent Toxicity |
7.1% |
| Weight Decreased |
7.1% |
| Electrocardiogram Change |
4.8% |
| Hepatic Lesion |
4.8% |
| Liver Injury |
4.8% |
| Stevens-johnson Syndrome |
4.8% |
| Urinary Tract Infection |
4.8% |
| Visual Acuity Reduced |
4.8% |
| Withdrawal Syndrome |
4.8% |
| Glomerular Filtration Rate Abnormal |
2.4% |
| Grand Mal Convulsion |
2.4% |
| Hepatitis Fulminant |
2.4% |
| Hepatosplenomegaly |
2.4% |
| Hypoaesthesia |
2.4% |
| Insomnia |
2.4% |
| Muscular Weakness |
2.4% |
|
| Concomitant |
| Pain |
16.8% |
| Drug Use For Unknown Indication |
12.1% |
| Product Used For Unknown Indication |
9.7% |
| Hypertension |
9.4% |
| Prophylaxis |
6.9% |
| Rheumatoid Arthritis |
5.9% |
| Non-small Cell Lung Cancer Stage Iv |
5.2% |
| Analgesic Therapy |
3.9% |
| Gastritis Prophylaxis |
3.4% |
| Tumour Pain |
3.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.0% |
| Thrombosis Prophylaxis |
3.0% |
| Chest Pain |
2.7% |
| Infection Prophylaxis |
2.6% |
| Non-small Cell Lung Cancer |
2.3% |
| Osteoporosis |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Constipation |
1.8% |
| Coronary Artery Disease |
1.8% |
| Restless Legs Syndrome |
1.8% |
|
| Clostridium Difficile Colitis |
7.6% |
| Cytokine Release Syndrome |
7.6% |
| Pain |
7.6% |
| Pseudomembranous Colitis |
7.6% |
| Tremor |
6.3% |
| Urinary Tract Infection |
6.3% |
| Weight Decreased |
6.3% |
| Wound Secretion |
6.3% |
| Suicide Attempt |
5.1% |
| Troponin Increased |
5.1% |
| Blood Pressure Increased |
3.8% |
| Facial Paresis |
3.8% |
| General Physical Health Deterioration |
3.8% |
| Pneumonia |
3.8% |
| Tachycardia |
3.8% |
| Vitamin B6 Deficiency |
3.8% |
| Wound Infection |
3.8% |
| Bloody Discharge |
2.5% |
| Bone Pain |
2.5% |
| C-reactive Protein Increased |
2.5% |
|
